SCHEMBL27666105

SCHEMBL27666105

Cc1ccccc1Oc1ccc2ccccc2n1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.61
▸ NPC1 O15118 2/20 0.61
▸ RAB9A P51151 2/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ TSHR P16473 1/20 0.61
▸ MAP4K4 O95819 1/20 0.52
▸ CYP1A2 P05177 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ NOTUM Q6P988 1/20 0.46
▸ NCF1 P14598 2/20 0.43
▸ MAPK14 Q16539 2/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP2C9 P11712 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1131286 0.80 NCF1 (0.50) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL31498821 0.80 NCF1 (0.50) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL1602780 0.79 HTR1B (0.44) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL10511286 0.79 HTT (0.63) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL27860982 0.79 MAP4K4 (0.52) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL10649068 0.79 HTT (0.42) MEN1KMT2ACYP1A2MAPTNCF1
SCHEMBL10675894 0.79 MEN1 (0.41) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL28691331 0.79 MEN1 (0.44) MEN1KMT2AMAP4K4CYP1A2MAPT
SCHEMBL10767713 0.79 ECE2 (0.42) SMN1; SMN2NPC1RAB9AMEN1KMT2A
Phosphine SCHEMBL23753735 0.78 MAPT (0.49) SMN1; SMN2NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 — — CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 — — CN disclosed
Send feedback